UB Paderborn / Katalog / Suche / in CDI

1 – 11 von 11

Sortiert nach

In Vitro Activity of the New Multivalent Glycopeptide-Cephalosporin Antibiotic TD-1792 against Vancomycin-Nonsusceptible Staphylococcus Isolates

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3799-3803

2010

Volltextzugriff (PDF)

Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus

Journal of antimicrobial chemotherapy, 2006-08, Vol.58 (2), p.338-343

2006

Volltextzugriff (PDF)

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

Therapeutics and clinical risk management, 2016-01, Vol.12 (Issue 1), p.931-940

2016

Volltextzugriff (PDF)

Impact of Enterococcus faecalis on the Bactericidal Activities of Arbekacin, Daptomycin, Linezolid, and Tigecycline against Methicillin-Resistant Staphylococcus aureus in a Mixed-Pathogen Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2006-04, Vol.50 (4), p.1298-1303

2006

Volltextzugriff (PDF)

Dalbavancin (BI-387) for the treatment of complicated skin and skin structure infection

Expert review of anti-infective therapy, 2015-02, Vol.13 (2), p.149-159

2015

Volltextzugriff (PDF)

Pulsatile Delivery of Clarithromycin Alone or in Combination with Amoxicillin against Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy, 2006-02, Vol.50 (2), p.813-816

2006

Volltextzugriff (PDF)

Antimicrobial Stewardship and Clostridium difficile–Associated Diarrhea

Journal of pharmacy practice, 2013-10, Vol.26 (5), p.506-513

2013

Volltextzugriff (PDF)

Review of Treatment Regimens for Mucormycosis in a Las Vegas County Hospital Between 2013 and 2017

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S87-S87

2017

Volltextzugriff (PDF)

Drug-Induced Hemolytic Anemia From Ceftazidime/Avibactam, A New Old Antimicrobial: A Case Report

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Real-world Evaluation of Ceftolozane/Tazobactam (C/T) Use and Clinical Outcomes at an Academic Medical Center in Las Vegas

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S296-S297

2017

Volltextzugriff (PDF)

1 – 11 von 11

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(11)

Sprache

Englisch
(11)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of the New Multivalent Glycopeptide-Cephalosporin Antibiotic TD-1792 against Vancomycin-Nonsusceptible Staphylococcus Isolates

Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

Impact of Enterococcus faecalis on the Bactericidal Activities of Arbekacin, Daptomycin, Linezolid, and Tigecycline against Methicillin-Resistant Staphylococcus aureus in a Mixed-Pathogen Pharmacodynamic Model

Dalbavancin (BI-387) for the treatment of complicated skin and skin structure infection

Pulsatile Delivery of Clarithromycin Alone or in Combination with Amoxicillin against Streptococcus pneumoniae

Antimicrobial Stewardship and Clostridium difficile–Associated Diarrhea

Review of Treatment Regimens for Mucormycosis in a Las Vegas County Hospital Between 2013 and 2017

Drug-Induced Hemolytic Anemia From Ceftazidime/Avibactam, A New Old Antimicrobial: A Case Report

Real-world Evaluation of Ceftolozane/Tazobactam (C/T) Use and Clinical Outcomes at an Academic Medical Center in Las Vegas

Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation

Suchergebnisse filtern